That theme creates big opportunities for consumer-oriented solutions that provide choice, information, and configurable benefits
who evaluated the effect of a parenteral administration in anxious and depressed mice: quercetin regulated serotonergic and cholinergic neurotransmission of mice, contrasting anxiety and depression, but also improved memory performance [44]
In this study, we primarily investigated the immunomodulatory effect of L-Cn on immune cells in chronic HBV infection
5.2 Alternative glycemic biomarkers and monitoring tools Integrating biochemical and sensor-based tools ensures dynamic assessment of glycemia in PDM
References: [1] Metsera Reports Highly Competitive Results from Ongoing Trial of Novel, Potential OnceMonthly Injectable GLP-1 Receptor Agonist MET-097 [2] Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity [3] A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings [4] Safety, tolerability and weight reduction findings of oral amycretin: a novel amylin and glucagon-like peptide-1 receptor co-agonist, in a first-in-human study
